Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryN/A
SectorFinance
Phone855-727-9079
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$242.67 million
Profitability
Miscellaneous
Employees523
OptionableOptionable
Trupanion (NASDAQ:TRUP) Frequently Asked Questions
What is Trupanion's stock symbol?
Trupanion trades on the NASDAQ under the ticker symbol "TRUP."
How were Trupanion's earnings last quarter?
Trupanion Inc (NASDAQ:TRUP) announced its quarterly earnings results on Thursday, November, 8th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.04. The financial services provider had revenue of $78.16 million for the quarter, compared to analyst estimates of $77.70 million. Trupanion had a negative return on equity of 2.45% and a negative net margin of 0.52%. The company's quarterly revenue was up 23.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.01 earnings per share. View Trupanion's Earnings History.
When is Trupanion's next earnings date?
What price target have analysts set for TRUP?
9 analysts have issued 12-month price objectives for Trupanion's stock. Their predictions range from $38.00 to $55.00. On average, they anticipate Trupanion's stock price to reach $45.25 in the next twelve months. This suggests a possible upside of 75.7% from the stock's current price. View Analyst Price Targets for Trupanion.
What is the consensus analysts' recommendation for Trupanion?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Trupanion.
Has Trupanion been receiving favorable news coverage?
Media stories about TRUP stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Trupanion earned a news impact score of 1.0 on InfoTrie's scale. They also gave news articles about the financial services provider a news buzz of 3.0 out of 10, meaning that recent media coverage is unlikely to have an effect on the stock's share price in the near future.
Who are some of Trupanion's key competitors?
Who are Trupanion's key executives?
Trupanion's management team includes the folowing people:
- Mr. Darryl Graham Andrew Rawlings, Founder, Pres, CEO & Director (Age 50)
- Ms. Tricia Lynn Plouf, Chief Financial Officer (Age 40)
- Mr. Asher Benjamin Bearman, Chief Admin. Officer & Sec. (Age 41)
- Mr. Howard Elliot Rubin, Director & Consultant (Age 66)
- Ms. Laura Bainbridge, Managing Director
Who are Trupanion's major shareholders?
Trupanion's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Investmentaktiengesellschaft Fuer Langfristige Investoren TGV (2.09%), Riverbridge Partners LLC (1.37%), Hamilton Lane Advisors LLC (0.09%) and Bank of Montreal Can (0.01%). Company insiders that own Trupanion stock include Asher Bearman, Darryl Rawlings, General Partner Ll Maveron III, Howard E Rubin, Ian Moffat, Margaret Tooth, Murray B Low, Robin A Ferracone and Tricia Plouf. View Institutional Ownership Trends for Trupanion.
Which institutional investors are selling Trupanion stock?
TRUP stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Hamilton Lane Advisors LLC and Bank of Montreal Can. Company insiders that have sold Trupanion company stock in the last year include Darryl Rawlings, Howard E Rubin, Margaret Tooth, Murray B Low and Tricia Plouf. View Insider Buying and Selling for Trupanion.
Which institutional investors are buying Trupanion stock?
How do I buy shares of Trupanion?
Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Trupanion's stock price today?
One share of TRUP stock can currently be purchased for approximately $25.75.
How big of a company is Trupanion?
Trupanion has a market capitalization of $860.57 million and generates $242.67 million in revenue each year. The financial services provider earns $-1,500,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. Trupanion employs 523 workers across the globe.
What is Trupanion's official website?
How can I contact Trupanion?
Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected]
MarketBeat Community Rating for Trupanion (NASDAQ TRUP)
MarketBeat's community ratings are surveys of what our community members think about Trupanion and other stocks. Vote "Outperform" if you believe TRUP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRUP will underperform the S&P 500 over the long term. You may vote once every thirty days.
